ARDELYX INC. - COMMON STOCK

Ardelyx, Inc. Reports Employment Inducement Grants

20 12月 2023 07:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

19 12月 2023 08:46:12 条件 NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

18 12月 2023 08:45:08 条件 NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

15 12月 2023 08:45:15 条件 NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

14 12月 2023 08:45:03 条件 NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

13 12月 2023 08:47:25 条件 NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

07 12月 2023 08:45:06 条件 NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

06 12月 2023 11:28:31 条件 NetDania Notify

Ardelyx, Inc. Reports Employment Inducement Grants

21 11月 2023 15:02:00 条件 Nasdaq GlobeNewswire

Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference

21 11月 2023 07:01:45 条件 Nasdaq GlobeNewswire

XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia

15 11月 2023 15:02:00 条件 Nasdaq GlobeNewswire

Ardelyx Announces Departure of Board Member

13 11月 2023 15:02:00 条件 Nasdaq GlobeNewswire

Ardelyx to Participate at the Jefferies London Healthcare Conference

10 11月 2023 07:05:00 条件 Nasdaq GlobeNewswire

Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States

06 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

03 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire

Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance

31 10月 2023 06:00:01 条件 Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

30 10月 2023 16:42:57 条件 Nasdaq GlobeNewswire

Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023

23 10月 2023 07:07:01 条件 Nasdaq GlobeNewswire

Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023

18 10月 2023 15:02:39 条件 Nasdaq GlobeNewswire

Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital

17 10月 2023 18:23:38 条件 Nasdaq GlobeNewswire